Table 3 Effect of PJ intake on the incidence rate, rate ratio and attributable risk of first and second CVD events

First event

PJ

$\frac{10}{648.24\mathit{PM}}\times 1000=\raisebox{1ex}{$15.42$}\!\left/ \!\raisebox{-1ex}{$1000\mathit{PM}$}\right.$

0.61

0.30 (0.25-1.5)

$\frac{\raisebox{1ex}{$25.03$}\!\left/ \!\raisebox{-1ex}{$1000\mathit{PM}$}\right.-\raisebox{1ex}{$15.42$}\!\left/ \!\raisebox{-1ex}{$1000\mathit{PM}$}\right.}{\raisebox{1ex}{$25.03$}\!\left/ \!\raisebox{-1ex}{$1000\mathit{PM}$}\right.}\times 100=38.4\mathit{\%}$

Placebo

$\frac{9}{359.57\mathit{PM}}\times 1000=\raisebox{1ex}{$25.03$}\!\left/ \!\raisebox{-1ex}{$1000\mathit{PM}$}\right.$

Second event

PJ

$\frac{2}{701.42\mathit{PM}}\times 1000=\raisebox{1ex}{$2.85$}\!\left/ \!\raisebox{-1ex}{$1000\mathit{PM}$}\right.$

0.54

0.55 (0.08-3.9)

$\frac{\raisebox{1ex}{$5.34$}\!\left/ \!\raisebox{-1ex}{$1000\mathit{PM}$}\right.-\raisebox{1ex}{$2.85$}\!\left/ \!\raisebox{-1ex}{$1000\mathit{PM}$}\right.}{\raisebox{1ex}{$5.34$}\!\left/ \!\raisebox{-1ex}{$1000\mathit{PM}$}\right.}\times 100=46.3\mathit{\%}$

Placebo

$\frac{2}{376.46\mathit{PM}}\times 1000=\raisebox{1ex}{$5.31$}\!\left/ \!\raisebox{-1ex}{$1000\mathit{PM}$}\right.$